News In Brief
This article was originally published in The Gray Sheet
Sales of Medtronic’s CoreValve blocked in Germany. Myriad Genetics sues BRCA test competitors. More news.
You may also be interested in...
Supreme Court asks solicitor general to weigh in on a suit against Medtronic with implications for federal pre-emption. In other Supreme Court updates, the court decided not to hear a completely separate appeal from Medtronic on a TAVR patent infringement suit; and a physician is trying to bring his stent patent case against Johnson & Johnson to the high court.
News Briefs: Injunction Against Medtronic TAVI Begins; Hospitals Spending Growing Faster Than Revenue
An injunction against sales in Germany of Medtronic’s CoreValve transcatheter aortic valve products begins. Moody’s reports hospital’s expenses grew faster in 2012 than their revenue, which is unsustainable, according to the ratings company. Volcano buys Medtronic’s Pioneer Plus catheters. Medtronic and Covidien open centers in Asia.
The company’s leadership team is “determined to transform Medtronic from being a primarily device provider today into the premier global medical technology solutions partner of tomorrow,” CEO Omar Ishrak said.